-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
IO Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q3 2025.
- IO Biotech, Inc. Operating Income (Loss) for the quarter ending September 30, 2025 was -$19.4M, a 27% increase year-over-year.
- IO Biotech, Inc. Operating Income (Loss) for the twelve months ending September 30, 2025 was -$92.1M, a 4.53% increase year-over-year.
- IO Biotech, Inc. annual Operating Income (Loss) for 2024 was -$95.2M, a 4.08% decline from 2023.
- IO Biotech, Inc. annual Operating Income (Loss) for 2023 was -$91.4M, a 28% decline from 2022.
- IO Biotech, Inc. annual Operating Income (Loss) for 2022 was -$71.4M, a 73.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)